Exploration of Anti-infectives From Mangrove-Derived Micromonospora sp. RMA46 to Combat Vibrio cholerae Pathogenesis

Hema Bhagavathi Sarveswari,Shanthini Kalimuthu,Karthi Shanmugam,Prasanna Neelakantan,Adline Princy Solomon
DOI: https://doi.org/10.3389/fmicb.2020.01393
IF: 5.2
2020-07-10
Frontiers in Microbiology
Abstract:<span><i>Vibrio cholerae</i>, the etiological agent of cholera, employs quorum sensing (QS) pathways to control the expression of virulence factors, including the production of cholera toxin and biofilm formation. Acquired antibiotic resistance in <i>V. cholerae</i> draws attention to the development of novel therapeutics that counteract virulence, rather than the viability of the pathogen. In this context, we explored the anti-infective potential of rare marine Actinobacteria (RMA) from a mangrove ecosystem. Here, we report the effects of <i>Micromonospora</i> sp. RMA46 against <i>V. cholerae in vitro</i>. The RMA46 organic extract was non-bactericidal to <i>V. cholerae</i> cells and non-cytotoxic to macrophage RAW264.7 cell lines. RMA46 inhibited the formation of <i>V. cholerae</i> biofilms and downregulated the QS global switches LuxO and HapR, as well as other virulence genes including <i>ct</i>, <i>tcp</i>, and <i>hap</i>A. <i>In silico</i> molecular docking simulation of RMA46 ethyl acetate extract with LuxO and HapR revealed that 2-methoxy-4-vinylphenol and hexahydro-3-(phenylmethyl)-pyrrolo[1,2-<i>a</i>]pyrazine-1,4-dione could interact with the active sites of LuxO and HapR and potentially inhibit them. This study highlights <i>Micromonospora</i> sp. RMA46 as a potential source of anti-infectives against <i>V. cholerae</i>.</span>
microbiology
What problem does this paper attempt to address?